Initial Tumor Size and Local Control in Stage III Non-Small Cell Lung Cancer Treated by Radio-Chemotherapy
Author(s) -
J.H. Karstens,
D. Andreopoulos,
J. Ammon
Publication year - 1990
Publication title -
oncology research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.553
H-Index - 48
eISSN - 2296-5262
pISSN - 2296-5270
DOI - 10.1159/000216743
Subject(s) - vindesine , cisplatin , stage (stratigraphy) , medicine , oncology , chemotherapy , lung cancer , biology , paleontology , vincristine , cyclophosphamide
In stage III non small cell lung cancer initial tumor size is a neglected prognostic factor. 22 patients with stage III disease have been treated with radio-chemotherapy (cisplatin/vindesine). A significant (p less than 0.001) influence of initial tumor size on local control can be demonstrated. Future treatment strategies should include initial tumor size.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom